Peptides get searched 10 million times a month. Most of those searches are actually about GLP-1 medications. But some are about something different — Sermorelin, NAD+, longevity treatments. Here's the honest breakdown, and the providers I looked at.
Most people searching "peptides for weight loss" are looking for semaglutide or tirzepatide — the GLP-1 medications in Wegovy and Zepbound. If that's you, the GLP-1 provider comparison is the right page. This page is about the other category — peptides that aren't GLP-1 receptor agonists.
Peptides are short chains of amino acids — the same building blocks as proteins, just smaller. Your body produces them naturally. Therapeutic peptides are synthetic versions prescribed to influence specific biological processes.
These are peptides — but a very specific category. They mimic the GLP-1 hormone to suppress appetite and regulate blood sugar. They're the ones with strong clinical weight-loss data. Compared on the GLP-1 page →
Sermorelin stimulates growth hormone release. NAD+ supports cellular energy and recovery. BPC-157 and TB-500 are under investigation for tissue repair. These are different products with different evidence bases and different regulatory status.
GLP-1 medications have years of large-scale clinical trial data behind them. Most other peptides have far thinner human evidence — often animal studies, small trials, or anecdotal reports. That doesn't mean they don't work. It means the evidence base is genuinely different.
On July 23–24, 2026, the FDA's Pharmacy Compounding Advisory Committee voted 6-of-7 to support adding BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax to the 503A Bulk Drug Substances list. This is not FDA approval — it's an advisory committee vote, and the FDA must still issue a proposed rule, run a public comment period, and publish a final rule before anything changes. That process takes months to years. But a near-unanimous advisory vote is a meaningful early signal worth tracking if you're interested in this category.
These are the providers I've looked at in this space. I'm not a doctor and this isn't medical advice — just the facts I could verify, laid out plainly. Run your own checks before signing up with any of them.
A physician-supervised telehealth platform combining GLP-1 weight loss (compounded and brand-name Wegovy, Ozempic, Mounjaro, Zepbound) with an NAD+ program. LegitScript certified. Every patient gets a free companion app for tracking dose, protein, and symptoms by photo or voice — with a full web version for anyone without a smartphone.
A telehealth platform focused on anti-aging and longevity treatments, offering physician-guided care across compounded peptides, hormone optimization, and metabolic support. A different category from GLP-1 weight loss — broader scope, longevity focus.
The first white-market peptide telehealth platform — physician-supervised protocols sourced from state-licensed 503A compounding pharmacies, available in all 50 states. Covers BPC-157, MOTS-c, GHK-Cu, CJC-1295/Ipamorelin, NAD+, and more. A legitimate prescription path for the peptides most commonly sought on the grey market.
I'm currently reviewing additional peptide and longevity telehealth providers. I'll add them here once I've verified enough about their medications, pricing, and terms to list them honestly. The same standard applies as the GLP-1 page — facts only, nothing I can't back up.
Semaglutide and tirzepatide are on a different page — compared side by side with verified pricing, formats, and terms.
Affiliate disclosure. This page contains affiliate links. If you sign up through a link here, AfterTheChange may earn a commission at no additional cost to you. Provider listings are based on publicly available information and personal research — not paid placements. This is not medical advice. Always consult a qualified healthcare professional before starting any prescription treatment.